Browsed by
Tag: psychopharmacology

Psychopharmacologic treatment of borderline personality disorder

Psychopharmacologic treatment of borderline personality disorder

Dialogues Clin Neurosci. 2013 Jun; 15(2): 213–224. PMCID: PMC3811092 PMID: 24174895 Luis H. Ripoll, MD* Author information Copyright and License information Disclaimer This article has been cited by other articles in PMC. Abstract The best available evidence for psychopharmacologic treatment of borderline personality disorder (BPD) is outlined here. BPD is defined by disturbances in identity and interpersonal functioning, and patients report potential medication treatment targets such as impulsivity, aggression, transient psychotic and dissociative symptoms, and refractory affective instability Few randomized…

Read More Read More

An Overview of the Association between Schizotypy and Dopamine

An Overview of the Association between Schizotypy and Dopamine

Front Psychiatry. 2014; 5: 184. Published online 2014 Dec 19. doi:  10.3389/fpsyt.2014.00184 PMCID: PMC4271513 PMID: 25566103 Christine Mohr1,* and Ulrich Ettinger2,* Author information ► Article notes ► Copyright and License information ► Disclaimer This article has been cited by other articles in PMC. Abstract Schizotypy refers to a constellation of personality traits that are believed to mirror the subclinical expression of schizophrenia in the general population. Evidence from pharmacological studies indicates that dopamine (DA) is involved in the etiology of…

Read More Read More